Search research articles
Contact Us
Filters
Showing results (441-450 of 502) with videos related to
Page
of 51
Sort By:
Journal of Neurovirology
|
February 14, 2022
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid
Dipesh Solanky, Jerel A Fields, Jennifer E Iudicello, et al.
Journal of Analytical Toxicology
|
June 26, 2021
Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers
Melissa A Hoffman, Jacqueline A Hubbard, Philip M Sobolesky, et al.
Neuroimage. Clinical
|
October 21, 2018
Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume
Katherine E MacDuffie, Gregory G Brown, Benjamin S McKenna, et al.
Msystems
|
October 14, 2020
Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV
Bryn C Taylor, Kelly C Weldon, Ronald J Ellis, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1
David Croteau, Scott Letendre, Brookie M Best, et al.
Fluids and Barriers of the CNS
|
April 22, 2017
Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults
Stephanie M Patton, Quan Wang, Todd Hulgan, et al.
AIDS (London, England)
|
March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIV
Rowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Clinical and Experimental Neuropsychology
|
January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals
Kenny Lin, Michael J Taylor, Robert Heaton, et al.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration
David Croteau, Steven S Rossi, Brookie M Best, et al.
Journal of Neurovirology
|
June 13, 2015
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease
Albert M Anderson, Christine Fennema-Notestine, Anya Umlauf, et al.
Page
of 51
Search research articles
Search
Showing results (441-450 of 502) with videos related to
Sort By:
Page
of 51
Journal of Neurovirology
|
February 14, 2022
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid
Dipesh Solanky, Jerel A Fields, Jennifer E Iudicello, et al.
Journal of Analytical Toxicology
|
June 26, 2021
Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers
Melissa A Hoffman, Jacqueline A Hubbard, Philip M Sobolesky, et al.
Neuroimage. Clinical
|
October 21, 2018
Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume
Katherine E MacDuffie, Gregory G Brown, Benjamin S McKenna, et al.
Msystems
|
October 14, 2020
Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV
Bryn C Taylor, Kelly C Weldon, Ronald J Ellis, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1
David Croteau, Scott Letendre, Brookie M Best, et al.
Fluids and Barriers of the CNS
|
April 22, 2017
Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults
Stephanie M Patton, Quan Wang, Todd Hulgan, et al.
AIDS (London, England)
|
March 15, 2019
Effects of comorbidity burden and age on brain integrity in HIV
Rowan Saloner, Robert K Heaton, Laura M Campbell, et al.
Journal of Clinical and Experimental Neuropsychology
|
January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals
Kenny Lin, Michael J Taylor, Robert Heaton, et al.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration
David Croteau, Steven S Rossi, Brookie M Best, et al.
Journal of Neurovirology
|
June 13, 2015
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease
Albert M Anderson, Christine Fennema-Notestine, Anya Umlauf, et al.
Page
of 51